News

Health~Holland Year in Review 2015

- We are pleased to publish the Health~Holland Year in Review 2015, our yearly magazine that brings you the developments from Top Sector Life Sciences & Health in 2015.

Top Team member Hans Schikan wins Roland Lageveen Award

- Tweejaarlijkse Award voor een persoon of organisatie die een uitzonderlijke bijdrage leverde aan het succes van de Nederlandse biotech sector.

Polyganics Receives 510,000 euros Clearance for Nerve Capping Device

- Polyganics, a privately held medical technology company focused on the commercialization of proprietary products and technologies for peripheral nerve repair, neurosurgery, general surgery, as well as ear, nose & throat surgery, announced it has received FDA 510,000 euros clearance for NEUROCAP, an innovative device designed to reduce painful neuroma formation and thereby facilitate tissue repair and regeneration.

#1 Healthcare in Europe according to the EHCI Report

- The Dutch receive the best care in Europe states the Euro Health Consumer Index 2015 report, released beginning of 2016.

Mimetas and Partners Receive 1.6 Million Dollar Industry Funding for Development of Organ-On-A-Chip Neurotoxicity Models

- Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip model for neurotoxicity. The aim of the project is to improve existing neurotoxicity tests and to reduce experimentation on animals.

Agendia and Partners Receive $6.8 million from European Commission to Study Targeted Therapies for Colorectal Cancer

- Agendia, Inc. and several European partners have received a $6.8 million European Commission grant to study targeted therapies for colorectal cancer (CRC). The grantees will test therapies matched to the molecular subtype of each patient’s tumor, to see if they are more effective than current therapies not keyed to a tumor’s subtype.

AstraZeneca enhances long-term growth through Oncology investment in Acerta Pharma

- Acerta Pharma has entered into a definitive agreement with AstraZeneca whereby AstraZeneca will acquire a majority stake in Acerta.

Collaboration Top Sectors results in 1.4 million for research projects on autonomy in dementia

- Samenwerking Topsectoren Creatieve Industrie en Life Sciences & Health levert 1,4 miljoen op voor onderzoek naar zelfstandigheid bij dementie. Twee grootschalige projecten met de namen FIT en Roodkapje maken aanspraak op de subsidie.

ZonMw Medical Inspirator Prize to collaboration patient and reseacher

- Frank Meijer, medeoprichter van Platform Congenitale Hernia Diafragmatica (CHD) en onderzoeker dr. Sanne Botden van het RadboudUMC kregen de Medische Inspirator uitgereikt door juryvoorzitter Elizabeth Vroom voor hun onderzoek naar CHD.

Treeway Announces Positive Data from Two Separate Phase I TW001 Clinical Trials

- Treeway, a biotech company developing therapies against amyotrophic lateral sclerosis (ALS), announced the completion of two successful phase I trials with their lead compound TW001, a new more patient friendly oral formulation of the Japanese stroke and ALS therapy edaravone.